Catalyst Wire Dossier Catalyst Wire Dossier

ZM-02 Injection

Modified Optogenetic Gene Therapy · Zhongmou Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZM-02 Injection, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection) [Phase 1, Phase 2]

See pricing